日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

CircRNA-mTOR Promotes Hepatocellular Carcinoma Progression and Lenvatinib Resistance Through the PSIP1/c-Myc Axis

环状RNA-mTOR通过PSIP1/c-Myc轴促进肝细胞癌进展和乐伐替尼耐药性

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202410591
Tang, Yongchang; Yuan, Feng; Cao, Mingbo; Ren, Yupeng; Li, Yuxuan; Yang, Gaoyuan; Zhong, Zhaozhong; Liang, Hao; Xiong, Zhiyong; He, Zhiwei; Lin, Nan; Deng, Meihai; Yao, Zhicheng
细胞生物学
肿瘤
mTOR
肿瘤免疫
发表日期：2025
文献求助 收藏

Exosome-derived hsa_circ_0007132 promotes lenvatinib resistance by inhibiting the ubiquitin-mediated degradation of NONO.

外泌体衍生的 hsa_circ_0007132 通过抑制 NONO 的泛素介导降解来促进乐伐替尼耐药性

期刊:Non-coding RNA Research
影响因子:4.7
doi:10.1016/j.ncrna.2025.05.007
Cao Mingbo, Li Yuxuan, Su Xiaorui, Tang Yongchang, Yuan Feng, Ren Yupeng, Deng Meihai, Yao Zhicheng
表观遗传
外泌体
发表日期：2025
文献求助 收藏

Machine learning-assisted multi-dimensional transcriptomic analysis of cytoskeleton-related molecules and their relationship with prognosis in hepatocellular carcinoma

利用机器学习辅助进行细胞骨架相关分子的多维转录组分析及其与肝细胞癌预后的关系

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-10056-4
Li, Yuxuan; Cao, Mingbo; Su, Xiaorui; Yang, Gaoyuan; Ren, Yupeng; He, Zhiwei; Shi, Zheng; Hu, Ziyi; Liang, Guirong; Zhang, Qi; Yao, Zhicheng; Deng, Meihai
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm clinical trial

低剂量环磷酰胺联合乐伐替尼、帕博利珠单抗和TACE治疗不可切除肝细胞癌的疗效和安全性：一项单中心、前瞻性、单臂临床试验

期刊:Chinese Journal of Cancer Research
影响因子:6.3
doi:10.21147/j.issn.1000-9604.2024.02.02
Ren, Yupeng; Li, Yuxuan; Cao, Mingbo; Tang, Yongchang; Yuan, Feng; Yang, Gaoyuan; He, Zhiwei; Shi, Zheng; Su, Xiaorui; Yao, Zhicheng; Deng, Meihai
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Advancements in understanding mechanisms of hepatocellular carcinoma radiosensitivity: A comprehensive review

肝细胞癌放射敏感性机制研究进展：一项综合综述

期刊:Chinese Journal of Cancer Research
影响因子:6.3
doi:10.21147/j.issn.1000-9604.2023.03.06
Yang, Gaoyuan; Yan, Huamei; Tang, Yongchang; Yuan, Feng; Cao, Mingbo; Ren, Yupeng; Li, Yuxuan; He, Zhiwei; Su, Xiaorui; Yao, Zhicheng; Deng, Meihai
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Identification of the hsa_circ_0039466/miR-96-5p/FOXO1 regulatory network in hepatocellular carcinoma by whole-transcriptome analysis

通过全转录组分析鉴定肝细胞癌中的hsa_circ_0039466/miR-96-5p/FOXO1调控网络

期刊:Annals of Translational Medicine
影响因子:
doi:10.21037/atm-22-3147
Yuan, Feng; Tang, Yongchang; Cao, Mingbo; Ren, Yupeng; Li, Yuxuan; Yang, Gaoyuan; Ou, Qifeng; Tustumi, Francisco; Levi Sandri, Giovanni Battista; Raissi, Driss; Pocha, Christine; Deng, Meihai; Yao, Zhicheng
肿瘤
肿瘤免疫
信号转导
FOXO1
细胞生物学
发表日期：2022
文献求助 收藏

The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis

肝细胞癌根治性切除术后伴微血管侵犯患者多种术后辅助治疗效果的系统评价和荟萃分析

期刊:Cancer Cell International
影响因子:6
doi:10.1186/s12935-021-01790-6
Yang, Jiarui; Liang, Hao; Hu, Kunpeng; Xiong, Zhiyong; Cao, Mingbo; Zhong, Zhaozhong; Yao, Zhicheng; Deng, Meihai
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression

HBV核心启动子突变和AKT上调S期激酶相关蛋白2，从而促进术后肝细胞癌进展。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/srep35917
Chen, Lubiao; Gu, Lin; Gu, Yurong; Wang, Hongbo; Deng, Meihai; Stamataki, Zania; Oo, Ye Htun; Huang, Yuehua
信号转导
AKT
肿瘤
细胞生物学
肿瘤免疫
发表日期：2016
文献求助 收藏